n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium has been researched along with Urinary-Bladder-Neoplasms* in 1 studies
1 other study(ies) available for n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium and Urinary-Bladder-Neoplasms
| Article | Year |
|---|---|
Incidental Papillary Bladder Carcinoma on 18F-Fluoromethylcholine PET/CT Undertaken to Evaluate Prostate Malignancy.
FDG PET is known to have a low sensitivity for the detection of prostate and bladder tumors because of high levels of urinary excretion, which potentially obscures sites of disease. Fluoromethylcholine PET has a higher sensitivity for the detection of metastatic prostate cancer compared with F-FDG PET, partly because of lower levels of urinary excretion. We present a case of a patient who underwent F-fluoromethylcholine PET for possible recurrent prostate cancer. The study identified an incidental, avid metachronous bladder tumor. We discuss the potential use of fluoromethylcholine PET in the detection of bladder tumors. Topics: Aged; Carcinoma, Papillary; Choline; Humans; Incidental Findings; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence; Urinary Bladder Neoplasms | 2017 |